Dr Ronenn Roubenoff
Global Head, Translational Medicine Discovery & Profiling, Novartis Institutes for Biomedical Research, USA
Talk title: "Innovative trial designs for proof of concept and beyond"
Ronenn Roubenoff is Global Head of Translational Medicine Discovery & Profiling at Novartis, Basel, CH, and Adjunct Professor of Medicine and Nutrition at Tufts University. An international authority on sarcopenia, translational medicine, and the use of biomarkers in drug development, he has published >270 papers (h-index 100). Awards include AOA and DO honor societies; Fellow of the American Colleges of Physicians and of Rheumatology; and the Robert H. Herman Award, American Society for Nutrition.